Nestlé is launching a A2 beta-casein protein infant formula product in Australia and New Zealand within the next two months, competing directly with first-mover a2 Milk.
Kiwi infant formula firm New Zealand New Milk is keen on increasing its market share in China, with new product development and the use of trusted retail platforms supporting its goal.
The ASEAN market presents a wealth of opportunity for Australian functional food firms, according to a joint report by the Commonwealth Scientific and Industrial Research Organisation (CSIRO) and auditor KPMG.
The humble broccoli, and its cruciferous cousins, including Brussels sprouts, cauliflower and cabbage, could help older people avoid being hospitalised after a fall, researchers at Edith Cowan University have revealed.
Irish brand VitHit expects its upcoming APAC debut to open doors for further expansion within the region for its sole product: a range of six functional bottled beverages developed as a healthy alternative to sugar-sweetened drinks.
Australian scientists have made a rare breakthrough in the study of Huntington's disease by finding that changes in the gut microbiome may influence its progress and treatment.
The Infant Nutrition Council in New Zealand has applied to the NZ Commerce Commission for an extension of the restriction on infant formula advertising, to prevent marketing to parents of children under a year old.
Nutraceutical firm ChromaDex will launch its TRU NIAGEN supplement in New Zealand next month via its exclusive distributor, local supplement brand Matakana Superfoods.
Bubs Australia’s current CEO Nicholas Simms has announced his resignation from the infant nutrition firm, with founder, MD and former CEO Kristy Carr to take over her previous duties once more.
Blackmores insists its recent supply chain challenges — documented in its half-yearly results six months ago — have now eased, with CEO Richard Henfrey adding that new measures would hopefully help to avoid future shortages.
Infant nutrition firm Bellamy's Organic has announced a 37% year-on-year growth in sales revenue to US$236.1m (A$329m) for the 2018 financial year, up from US$172.3m (A$240m) in 2017.
The debate about what constitutes 'good evidence', always a controversial point, has recently become even more heated, writes complementary medicines consultant Michael Smith.
Nelson-based supplements and cosmetics contract manufacturer Alaron Products has been named the winner of the first Supplier of the Year Award for New Zealand's natural health products industry.
